Recombinant vaccinia viruses protect against Clostridium perfringens α-toxin

被引:23
作者
Bennett, AM
Lescott, T
Phillpotts, RJ
Mackett, M
Titball, RW
机构
[1] Def Evaluat & Res Agcy, Salisbury, Wilts, England
[2] Christie Hosp, Paterson Inst Canc Res, Manchester, Lancs, England
关键词
D O I
10.1089/vim.1999.12.97
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recombinant vaccinia viruses that expressed the nontoxic C-domain of Clostridium perfringens alpha-toxin were constructed. The J2R (thymidine kinase [TK] gene) and B13R (serpin 2 [SPI-2] gene) loci were used as insertion sites for the clostridial DNA, and expression of the foreign protein was measured in each case. A double recombinant that encoded the alpha-toxin truncate at the B13R locus and the protective antigen of Bacillus anthracis at the J2R locus was also constructed. Although differences in expression of the alpha-toxin C-domain were recorded, all of the vaccinia recombinants protected mice against a lethal challenge with alpha-toxin demonstrating that a recombinant vaccinia virus can be used to provide protection against a toxin challenge that is known to be solely antibody mediated.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 31 条
[11]   PROTECTION AGAINST ANTHRAX WITH RECOMBINANT VIRUS-EXPRESSED PROTECTIVE ANTIGEN IN EXPERIMENTAL-ANIMALS [J].
IACONOCONNORS, LC ;
WELKOS, SL ;
IVINS, BE ;
DALRYMPLE, JM .
INFECTION AND IMMUNITY, 1991, 59 (06) :1961-1965
[12]  
Jezek Z., 1988, HUMAN MONKEYPOX, V17
[13]   A RECOMBINANT VACCINIA VIRUS EXPRESSING HEPATITIS-A VIRUS STRUCTURAL POLYPEPTIDES - CHARACTERIZATION AND DEMONSTRATION OF PROTECTIVE IMMUNOGENICITY [J].
KARAYIANNIS, P ;
OROURKE, S ;
MCGARVEY, MJ ;
LUTHER, S ;
WATERS, J ;
GOLDIN, R ;
THOMAS, HC .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :2167-2172
[14]   Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1 beta-induced fever [J].
Kettle, S ;
Alcami, A ;
Khanna, A ;
Ehret, R ;
Jassoy, C ;
Smith, GL .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :677-685
[15]   VACCINIA VIRUS SERPINS B13R (SPI-2) AND B22R (SPI-1) ENCODE M(R) 38.5K AND 40K, INTRACELLULAR POLYPEPTIDES THAT DO NOT AFFECT VIRUS VIRULENCE IN A MURINE INTRANASAL MODEL [J].
KETTLE, S ;
BLAKE, NW ;
LAW, KM ;
SMITH, GL .
VIROLOGY, 1995, 206 (01) :136-147
[16]   ANCHORING A SECRETED PLASMODIUM ANTIGEN ON THE SURFACE OF RECOMBINANT VACCINIA VIRUS-INFECTED CELLS INCREASES ITS IMMUNOGENICITY [J].
LANGFORD, CJ ;
EDWARDS, SJ ;
SMITH, GL ;
MITCHELL, GF ;
MOSS, B ;
KEMP, DJ ;
ANDERS, RF .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (09) :3191-3199
[17]  
MACPHERSON WG, 1922, OFFICIAL HIST WAR, V1, P134
[18]  
McDonel J. L., 1986, Pharmacology of bacterial toxins, P477
[19]   ENTEROTOXIGENIC BACTERIA IN THE SUDDEN-INFANT-DEATH-SYNDROME [J].
MURRELL, WG ;
STEWART, BJ ;
ONEILL, C ;
SIARAKAS, S ;
KARIKS, S .
JOURNAL OF MEDICAL MICROBIOLOGY, 1993, 39 (02) :114-127
[20]   Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes [J].
Nam, JH ;
Wyatt, LS ;
Chae, SL ;
Cho, HW ;
Park, YK ;
Moss, B .
VACCINE, 1999, 17 (03) :261-268